Skip to content

Contract award record

Hereditary Angioedema

Notice details

Published
Category
goods
Buyer region
North West

Public buyer and contract winner

Public buyer

NHS England
awarded to

Contract winner

Martindale Pharma

Award value£74,500,000

  1. Awarded
    Completed
  2. Start
    Completed
  3. End
    Completed

Work description

NHS National Framework Agreement for the supply of products for the management of Hereditary Angioedema. Period of framework agreement: 1 July 2022 to 31 December 2023 with an option or options to extend (at the Authority's discretion) for a period or periods up to a total of 30 months. Total maximum framework agreement including extension options will be no more than 48 months

Related awards

Source: Contracts Finder · Notice 1132440f-b206-4c8a-9c65-84276d8d2f77-556317

View source notice